These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1352370)

  • 1. Best mode of expression of acute reversibility of airway obstruction in patients with asthma: application to a new beta-2 agonist, RU 42 173.
    Lurie A; Vivet P; Letrait M; Venot A; de Lauture D; Lockhart A; Marsac J; Srauch G
    Methods Find Exp Clin Pharmacol; 1992; 14(1):29-33. PubMed ID: 1352370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.
    Singh D; Pujol H; Ribera A; Seoane B; Massana E; Astbury C; Ruiz S; de Miquel G
    BMC Pulm Med; 2014 Nov; 14():176. PubMed ID: 25398689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I; Williams M; Power S; Pilcher J; Weatherall M; Baines A; Moynihan J; Kempsford R; Beasley R;
    Respir Med; 2016 Oct; 119():115-121. PubMed ID: 27692131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselective beta-blocker use in patients with reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2001; 2002(2):CD002992. PubMed ID: 11406056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.
    Brand PL; Quanjer PH; Postma DS; Kerstjens HA; Koëter GH; Dekhuijzen PN; Sluiter HJ
    Thorax; 1992 Jun; 47(6):429-36. PubMed ID: 1496502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
    O'Byrne PM; D'Urzo T; Beck E; Fležar M; Gahlemann M; Hart L; Blahova Z; Toorawa R; Beeh KM
    Respir Res; 2015 Aug; 16(1):97. PubMed ID: 26283085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J; Langley S; Woodcock A
    Respir Res; 2006 Aug; 7(1):110. PubMed ID: 16919161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED
    Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases.
    Bayiz H; Ozkaya S; Dirican A; Ece F
    Drug Des Devel Ther; 2015; 9():5287-90. PubMed ID: 26451084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
    Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchodilator response in elderly patients].
    Quadrelli SA; Roncoroni AJ; Sacerdotti A
    Medicina (B Aires); 2001; 61(3):257-61. PubMed ID: 11474869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bronchodilator response: comparison of four indices.
    Chhabra SK; Vijayan VK; Gupta R; De S
    Respir Med; 2002 Aug; 96(8):611-4. PubMed ID: 12195842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility test in the early stages of bronchial asthma.
    Mariotta S; Sposato B; Ricci A; Bruno P; Aquilini M; Mannino F
    J Asthma; 2005; 42(6):487-91. PubMed ID: 16293544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
    Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the endothelin-1 receptor antagonist, bosentan, on patients with poorly controlled asthma: a 17-week, double-blind, placebo-controlled crossover pilot study.
    Coyle TB; Metersky ML
    J Asthma; 2013 May; 50(4):433-7. PubMed ID: 23363065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.